Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected...

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Safety

Background:

• Fluoroquinolone (FQ) antibiotics are among the most frequently prescribed antibacterial agents globally.
• Despite being available for over two decades, significant FQ-associated adverse events have been recognized since 2006.
• This study focuses on adverse events linked to commonly prescribed FQs: ciprofloxacin, levofloxacin, and moxifloxacin.

Purpose of the Study:

• To document and analyze reported adverse events associated with widely used fluoroquinolone antibiotics.
• To highlight the spectrum and timeline of serious side effects linked to FQ use.

Main Methods:

• Case reporting of adverse events in individuals consuming specific fluoroquinolone antibiotics.
• Review of adverse event data spanning a 15-year period.

Main Results:

• Individuals reported various adverse events after taking common fluoroquinolone antibiotics.
• Serious FQ-associated adverse events have been a recognized concern for an extended period.

Conclusions:

• Commonly prescribed fluoroquinolones like ciprofloxacin, levofloxacin, and moxifloxacin are associated with a range of adverse events.
• The recognition of serious FQ-associated adverse events has persisted for many years, underscoring the need for ongoing vigilance.